We never saw the ink. I suspect that announcements of supplier were based on a handshake or phonecall Hargrove spun into story in his mind.
If an agreement is actually in place, there is NO reason to withhold that from shareholders.
We have all gotten so used to the virtually zero information coming out of Titan we have ceased to question the obvious, like what exactly being worked on at this moment by Ximedica. I'm not talking about revealing IP to the competition, but how about some idea of progress towards a CE, FDA submit-able device?
News 
Market Data 
Discover 
AI
